BPN14770

About

BPN14770 is a small molecule drug candidate being investigated for its potential therapeutic applications. It acts as a selective phosphodiesterase 2 (PDE2) inhibitor, a mechanism that may influence various cellular signaling pathways.

This compound is currently in preclinical development, with research focusing on its effects in areas such as cognitive function and neurodegenerative disorders. It is intended for researchers and medical professionals studying novel pharmacological interventions for conditions where PDE2 inhibition may offer a therapeutic benefit.